Ozempic has, in the recent times, become popular for weight loss, but new research hints it may hamper muscle strength, even ...

Two new JAMA Network Open studies link popular diabetes and weight loss drugs, including Ozempic and Mounjaro, to a slightly ...

A study published in JAMA Network, by the Case Western Reserve University examined about 15,11,637 eligible participants with ...

There is zero evidence that ​​semaglutides can increase the size of your crown jewels. What may happen is that as you lose ...

As Sky News research revealed thousands of severely obese patients are facing severely delayed treatment, here we look at the ...

Nutritional approaches featuring reduced carbohydrates alongside elevated protein and fibre content trigger the release of ...

New studies found that Americans with type 2 diabetes who are taking GLP-1 drugs like Ozempic and Mounjaro could face an increased risk of rare eye conditions.

A sweeping analysis of global studies reveals that stopping weight loss drugs, including well-known treatments like Ozempic and Wegovy, often triggers a rapid return of lost pounds.

Three new studies suggest that Ozempic and related diabetes and weight loss drugs may help protect the brain from strokes.

One study found a modest risk of developing non-arteritic anterior ischaemic optic neuropathy (NAOIN), a rare eye condition ...